Michael J F Blumer Selected Research

human KAT2A protein

1/2022

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J F Blumer Research Topics

Disease

2	Ischemia 01/2017 - 10/2014
1	Heart Diseases (Heart Disease) 01/2022
1	Heart Failure 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Necrosis 03/2015
1	Inflammation (Inflammations) 10/2014
1	Reperfusion Injury 10/2014
1	Sepsis (Septicemia) 05/2013
1	Hearing Loss (Hearing Impairment) 05/2013
1	Spinal Dysraphism (Spina Bifida) 01/2009
1	Hyperalgesia 05/2008
1	Neoplasms (Cancer) 05/2008

Drug/Important Bio-Agent (IBA)

2	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 10/2014
2	Histidine (L-Histidine)FDA Link 01/2017 - 10/2014
1	LipidsIBA 01/2022
1	EnzymesIBA 01/2022
1	human KAT2A proteinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	SolutionsIBA 10/2014
1	Glutamic Acid (Glutamate)FDA Link 05/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2008
1	Etanercept (Enbrel)FDA Link 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2008
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2008

Therapy/Procedure

1	Vascularized Composite Allotransplantation 10/2014
1	Transplantation 10/2014
1	Critical Care (Surgical Intensive Care) 05/2013
1	Punctures 05/2013
1	Ligation 05/2013